Daniele G.
- Country
- Italy
- Department
- SC EMATOLOGIA
Research Overview
Data & Insights
Has run more than one trial at 0 of 28 partner sites.
Specializations
Hematologic Oncology
This investigator specializes in the treatment of Acute Myeloid Leukemia (AML), with particular expertise in cases involving NPM1 mutations. Their research focuses on innovative therapeutic approaches for blood cancers.
- Molecular-based Leukemia Treatment
- NPM1 Mutation Analysis
- Hematologic Malignancies
The investigator's work encompasses advanced therapeutic strategies for addressing genetic mutations in blood disorders.
Targeted Therapies
The investigator has developed expertise in combination therapy approaches, particularly focusing on targeted treatments for hematologic conditions. Their work involves evaluating novel drug combinations to enhance treatment efficacy.
- Combination Drug Strategies
- Targeted Treatment Protocols
- Therapeutic Response Assessment
Their research explores innovative therapeutic combinations to improve patient outcomes in blood cancers.
Molecular Monitoring
Specializing in molecular relapse prevention and monitoring, the investigator focuses on developing strategies to prevent disease progression in AML patients. Their expertise includes tracking molecular markers for early intervention.
- Disease Progression Monitoring
- Molecular Marker Analysis
- Relapse Prevention Strategies
The work encompasses sophisticated monitoring techniques for tracking treatment response in leukemia patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.